Physician
Andrew Bennett Brown, M.D.
According to 2025 Medicare claims, Andrew Brown, M.D. (NPI: 1386800464) practices hematology/oncology in the Newark, NJ market, with the plurality of this provider's patient population coming from Essex, NJ. This provider's primary affiliated billing organization is BARNABAS HEALTH MEDICAL GROUP PC (NPI: 1841557246; TIN: 454832340) and primary practice location at 07039-5672. Brown is affiliated with the RWJBH Accountable Care, LLC (ACO ID: A1247), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.
Brown's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 316 traditional Medicare patients, billed 1,243 HCPCS/CPT codes, and received $119,264 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,241 prescription claims across 270 beneficiaries totaling $2,942,898 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 78 claims. Open Payments data shows 12 records totaling $290. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $221,728 to $2,942,898. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.